Phanes Therapeutics

Phanes Therapeutics

Edit info

  • Founded: 2016
  • Location: San Diego, CA
  • Employee range: 1 - 10
  • Clinical stage: Clin1
  • Therapy area: Solid tumors
  • Drug types: ONC
  • Lead product: PT199
  • Funding: $40M B May 2021


phanesthera.com

linkedin.com

job board


Drug notes:

PT886 Clin1 multiple cancers (ODD); PTC-217 Clin1 cancers; 15 add'l products early stage

About:

Phanes Therapeutics is focused on innovative drug discovery in immuno-oncology. Antibiotic-based biologics have much potential in therapies due to their specificity and modularity. Phanes is building native IgG-like bispecific antibodies that enhance drug-like properties. Currently, Phane has three technology platforms: PACbody, to create bispecific antibodies, SPECpair, to enhance manufacturability of bispecific antibodies and ATACCbody, to build bispecific antibodies with modulated activities. Using this approach, Phanes has established a diverse pipeline with some programs in clinical studies.

Jobs:

Post a job


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com